Many things about the modern world we take for granted. Personal computers, cellphones, GPS — these things are ubiquitous now but were far less common just a few decades ago. That’s a great thing for ...

For NY - Difficulty Level: For both newly admitted & experienced attorneys For NY - Difficulty Level: Both newly admitted and experienced attorneys As the COVID-19 crisis stretches into its third year ...

Navigating the balance between protecting innovation and ensuring access to affordable medications is crucial. Join Jason A. Lief of Windels Marx and William C. Baton of Saul Ewing LLP in this CLE ...

The Association for Accessible Medicines released a report touting the lasting benefits the generic drug industry has provided to patients, employers and taxpayers in the 40 years since the enactment ...

NEW YORK, March 20, 2024 /PRNewswire/ -- WIT Legal ("WIT"), the leading agency representing testifying experts for high-stakes, complex legal matters, today released a new report that evaluates 2023 ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Torie Bosch is the First Opinion editor at STAT. First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Amin is the co-founder and CEO of the Initiative for Medicines, Access & Knowledge (I-MAK). Timi Iwayemi is a research director at the Revolving Door Project. As the Hatch-Waxman Act approaches its ...

One often overlooked factor is that established pharmaceutical companies have been working with big government to short-circuit the free market and make it impossible for generic medicines to compete.